Revolution Medicines (FRA:42Z) Ending Cash Position : €522.16 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Revolution Medicines Ending Cash Position?

Revolution Medicines's Ending Cash Position for the quarter that ended in Dec. 2024 was €522.16 Mil.

Revolution Medicines's quarterly Ending Cash Position declined from Jun. 2024 (€258.95 Mil) to Sep. 2024 (€183.94 Mil) but then increased from Sep. 2024 (€183.94 Mil) to Dec. 2024 (€522.16 Mil).

Revolution Medicines's annual Ending Cash Position increased from Dec. 2022 (€154.01 Mil) to Dec. 2023 (€641.15 Mil) but then declined from Dec. 2023 (€641.15 Mil) to Dec. 2024 (€522.16 Mil).

Revolution Medicines Ending Cash Position Historical Data

The historical data trend for Revolution Medicines's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revolution Medicines Ending Cash Position Chart

Revolution Medicines Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

86.60

97.56

154.01

641.15

522.16

Revolution Medicines Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															641.15	268.15	258.95	183.94	522.16

Revolution Medicines Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Revolution Medicines's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	667.716	+	-145.558
	=	522.16

Revolution Medicines's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	194.963	+	327.195
	=	522.16

Revolution Medicines Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Revolution Medicines's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Revolution Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Revolution Medicines Inc (FRA:42Z) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

RVMD:USA

Address

700 Saginaw Drive, Redwood City, CA, USA, 94063

Website

https://www.revmed.com

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Revolution Medicines Headlines

No Headlines